| Income Statement |
| Total Revenue | 1.09B |
|
| Revenues (USD) | 1.09B |
| Cost of Revenue | 602.24M |
| Gross Profit | 483.28M |
| Operating Expenses | 347.49M |
| Research and Development Expense | 87.07M |
| Selling, General and Administrative Expense | 256.58M |
| Operating Income | 135.79M |
| Income Tax Expense | 6.39M |
| Net Income | 143.46M |
| Net Income Common Stock | 143.46M |
| Net Income Common Stock (USD) | 143.46M |
| Consolidated Income | 143.46M |
| Earnings per Basic Share | 0.99 |
| Earnings per Basic Share (USD) | 0.99 |
| Earnings per Diluted Share | 0.98 |
| Earning Before Interest & Taxes (EBIT) | 149.85M |
| Earning Before Interest & Taxes (USD) | 149.85M |
| Weighted Average Shares | 145.31M |
| Weighted Average Shares Diluted | 146.93M |
| Balance Sheet |
| Cash and Equivalents | 1.74B |
| Cash and Equivalents (USD) | 1.74B |
| Trade and Non-Trade Receivables | 505.87M |
| Current Assets | 2.92B |
| Property, Plant & Equipment Net | 116.45M |
| Total Assets | 3.85B |
| Current Liabilities | 1.31B |
| Total Liabilities | 1.64B |
| Accumulated Retained Earnings (Deficit) | 3.38B |
| Accumulated Other Comprehensive Income | -113.82M |
| Shareholders Equity | 2.21B |
| Shareholders Equity (USD) | 2.21B |
| Assets Non-Current | 933.33M |
| Goodwill and Intangible Assets | 477.80M |
| Inventory | 489.95M |
| Liabilities Non-Current | 324.22M |
| Trade and Non-Trade Payables | 530.98M |
| Tax Liabilities | 86.32M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 18.55M |
| Net Cash Flow from Financing | -267.44M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -76.27M |
| Capital Expenditure | -13.84M |
| Issuance (Purchase) of Equity Shares | -265.41M |
| Net Cash Flow from Investing | -13.63M |
| Net Cash Flow - Investment Acquisitions and Disposals | 668.00K |
| Net Cash Flow from Operations | 202.79M |
| Effect of Exchange Rate Changes on Cash | 2.01M |
| Share Based Compensation | 25.82M |